Overall, COVID-19 is not expected to have a major impact on consumer health in Nigeria and it expected that current value growth in 2020, will be similar to 2019 and will continue to register double-digit growth, as it has over the review period. However, drilling down within the product area, there are certain products that will benefit from...
Following the emergence of COVID-19 in Greece and the announcement of lockdown measures in March in a bid to control the spread of the virus, consumers took to stockpiling basic medicines such as acetaminophen, various cough and cold remedies including nasal sprays and pharyngeal preparations to equip themselves against various symptoms, in...
2020 is not expected to be a good year for consumer health in Thailand, with a strong current value decline expected, after seeing strong growth in all other years of the review period. At the beginning of the year the country was already suffering from a soft economic environment, as well as other factors, including droughts, high household...
Allergic Conjunctivitis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis - Pipeline Review, H2 2020, provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline landscape. Allergic conjunctivitis occurs...
COVID-19 had a significant impact on consumer health in Austria in 2020 with it resulting in consumers reassessing their priorities and focusing on their immediate concerns. As concerns rose about the threat posed by COVID-19 many households started stocking up on products that were perceived to treat the symptoms of the virus, such as analgesics...
Ophthalmic Drugs Market Research Report by Disease Condition (Allergy, Dry Eye Disorder, Glaucoma, and Retinal Disorder), by Dispense Type (Over the Counter and Prescription) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major...
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Conjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on...
Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
Overall consumer health is not expected to see a significant difference in its growth rate in 2020 compared with the previous year, with just a marginally higher current value increase. However, the emergence of the COVID-19 virus in the country at the beginning of the year had different impacts on different consumer health categories. Consumer...